Dark

MLTX
MoonLake Immunotherapeutics Class A
stock NASDAQ

At Close

Jan 9, 2026 3:59:57 PM EST

18.52USD+29.149%(+4.18)14,270,627

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jan 9, 2026 9:28:30 AM EST

15.29USD+6.625%(+0.95)98,742

After-hours

Jan 9, 2026 4:58:30 PM EST

18.83USD+1.674%(+0.31)485,700

OverviewOptionsHistoricalExchangesShortsTrends

open chart

Market Cap

1.31B

Industry

Biotechnology

Next Earnings

Feb 25, 2026 (46d)

MLTX Stats

Avg. Vol. 10 Day

5,061,614

Avg. Vol. 30 Day

2,850,175

Employees

Market Cap

1,310,676,918

Shares Out.

70,847,401

On/Off Exchange

55%/45%

6 Month Beta

0.29

1 Year Beta

0.67

2 Year Beta

0.77

3 Year Beta

0.74

52 Week Low

5.95

52 Week High

62.75

SMA50

12.95

SMA200

34.26

1 Week

+54.81%

1 Month

+26.63%

3 Month

+80.31%

6 Month

-62.15%

1 Year

-60.06%

2 Year

-67.62%

5 Year

+43.63%

Profile

moonlake immunotherapeutics ag is a clinical-stage biopharmaceutical company leveraging revolutionary nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

MLTX Stock Summary

MoonLake Immunotherapeutics Class A (NASDAQ:MLTX) stock price today is $18.52, and today's volume is 14,270,627. MLTX is up 29.149% today. The 30 day average volume is 2,850,175. MLTX market cap is 1.31B with 70,847,401 shares outstanding.

.dark-mode .p2TC5v{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .p2TC5v{ color: #333333; background-color: white; border: 2px solid #333333; }MLTXMoonLake Immunotherapeutics Class Astock NASDAQ

MLTX Stock Summary

MLTX
MoonLake Immunotherapeutics Class A
stock NASDAQ